Back to full study details
Waterloo, IANow Enrolling

Lung Cancer Clinical Trial in Waterloo, IA

Access cutting-edge lung cancer treatment through this clinical trial at a research site in Waterloo. Study-provided care at no cost to qualified participants.

Expert Care

Access lung cancer specialists in Waterloo at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lung cancer treatment provided free

About This Lung Cancer Study in Waterloo

The purpose of ARTEMIDE-Lung04 is to assess the efficacy and safety of rilvegostomig compared with pembrolizumab monotherapy as 1L treatment in participants with mNSCLC and whose tumors express PD-L1.

Sponsor: AstraZeneca

Apply for This Waterloo Location

Check if you qualify for this lung cancer clinical trial in Waterloo, IA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Lung Cancer Treatment Options in Waterloo, IA

If you're searching for lung cancer treatment options in Waterloo, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Waterloo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Why Consider a Clinical Trial for Lung Cancer?

  • Access to new treatments before they're widely available
  • Receive care from leading lung cancer specialists in Waterloo
  • Contribute to medical research that could help future patients
  • Study-related care is typically provided at no cost
  • Close monitoring by a dedicated research team
  • Possible compensation for time and travel